GH Q1 2025 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q1 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$203M+20.8% YoY

Gross Profit

$129M63.3% margin

Operating Income

-$111M-54.6% margin

Net Income

-$95M-46.8% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

+0.8%

Cash Flow

Operating Cash Flow

-$63M

Free Cash Flow

-$67M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.6B

Stockholders' Equity

-$251M

Cash & Equivalents

$699M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$203M	$168M	+20.8%
Gross Profit	$129M	$103M	+24.8%
Operating Income	-$111M	-$100M	-11.4%
Net Income	-$95M	-$115M	+17.2%

Revenue Segments

Oncology

$151M74%

Biopharma & Data

$45M22%

Screening

$6M3%

Licensing & Other

$2M1%

Geographic Segments

UNITED STATES

$194M95%

Non-US

$10M5%